CureBay, a healthcare startup, has secured approximately Rs 62 crore in a funding round, primarily backed by its existing investor, Elevar Equity. The company outlined its plans to utilize the funds towards enhancing healthcare accessibility in underserved areas, developing a robust data platform, and expanding its team by hiring skilled professionals in technology and healthcare. Previously, in November 2022, CureBay had obtained Rs 50 crore in funding from Elevar Equity. Emphasizing its focus on achieving profitability and capitalizing on data assets, the company aims to invest in revenue-generating avenues like its membership program and bolstering its data expertise both in technology and market outreach, as stated in their official communication.

CureBay intends to utilize the funding to recruit over 200 professionals, encompassing data scientists and healthcare experts across diagnostics and pharmacy. The company's strategy involves expanding its clinics, aiming to elevate the count from 90 to more than 200 in regions spanning Odisha, Chhattisgarh and Jharkhand. Priyadarshi Mohapatra, CureBay's founder and CEO, highlighted their innovative approach, combining data and technology to enhance affordability and provide distinctive solutions for healthcare challenges at the grassroots level.

Jyotsna Krishnan, Managing partner at Elevar Equity, expressed admiration for CureBay's distinctive approach. Krishnan emphasized that CureBay is not solely focused on being a telemedicine provider or a delivery aggregator. Instead, the company's blended distribution model, strengthened by technology, is well-equipped to address a significant gap. Millions of customers in medically underserved regions seek timely, high-quality healthcare and are willing to pay for it, making CureBay's approach highly relevant and impactful.